Injecting drug use as risk factor for visceral leishmaniasis in AIDS patients

被引：22
|
作者：
Amela, C
LopezGay, D
Alberdi, JC
Castilla, J
机构：
[1] National Centre for Epidemiology, 'Carlos III' Institute of Health, Madrid
[2] Servicio de Epidemiología, Consejería de Salud, Madrid
[3] Centro Nacional de Epidemiología, E-28029 Madrid, c/ Sinesio Delgado
来源：
EUROPEAN JOURNAL OF EPIDEMIOLOGY | 1996年 / 12卷 / 01期
关键词：
AIDS; injecting drug use; leishmaniasis;
D O I：
10.1007/BF00144435
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
In Madrid Region 6652 AIDS cases were diagnosed between 1982 and 1993. Visceral leishmaniasis (VL) was present in 166 (2.49%). VL frequency among injecting drug users proved higher than that for the other transmission categories (relative risk 2.57; 95% confidence interval 1.64-4.01). This could point to an alternative Leishmania transmission route via needle sharing.
引用
收藏
页码：91 / 92
页数：2
相关论文
共 50 条
  • [41] Are non-injecting opioid users at risk of transition to injecting drug use? A multi-site study from India
    Ambekar, Atul
    Mishra, Ashwani
    Parmar, Arpit
    Kumar, Rajesh
    Kumar, Manish
    Rao, Ravindra
    Agrawal, Alok
    ASIAN JOURNAL OF PSYCHIATRY, 2019, 42 : 79 - 84
  • [42] Exploring associations between perceived HCV status and injecting risk behaviors among recent initiates to injecting drug use in Glasgow
    Palmateer, Norah
    Anderson, Niall
    Wadd, Sarah
    Hutchinson, Sharon
    Taylor, Avril
    Goldberg, David
    SUBSTANCE USE & MISUSE, 2008, 43 (3-4) : 375 - 388
  • [43] The Risk Environment for Adopting and Continuing Injecting Drug Use: A Qualitative Study in Uyo, Nigeria
    Nelson, Ediomo-Ubong E.
    Obot, Isidore S.
    SUBSTANCE USE & MISUSE, 2020, 55 (03) : 405 - 413
  • [44] HOMELESSNESS AMONG INJECTING DRUG-USERS - IMPLICATIONS FOR THE SPREAD OF AIDS
    KLEE, H
    JOURNAL OF COMMUNITY & APPLIED SOCIAL PSYCHOLOGY, 1991, 1 (02) : 143 - 154
  • [45] INTERNATIONAL EPIDEMIOLOGY OF HIV AND AIDS AMONG INJECTING DRUG-USERS
    DESJARLAIS, DC
    FRIEDMAN, SR
    CHOOPANYA, K
    VANICHSENI, S
    WARD, TP
    AIDS, 1992, 6 (10) : 1053 - 1068
  • [46] Imported visceral leishmaniasis and immunosuppression in seven Norwegian patients
    Schwartz, Thomas
    Jensenius, Mogens
    Blomberg, Bjorn
    Fladeby, Cathrine
    Maeland, Arild
    Pettersen, Frank O.
    TROPICAL DISEASES TRAVEL MEDICINE AND VACCINES, 2019, 5 (01)
  • [47] Visceral Leishmaniasis in HIV-Infected Patients: The Challenge of Relapse and Treatment Failure
    Cipriano, Patricia
    Miranda, Ana Claudia
    Antunes, Isabel
    Mansinho, Kamal
    ACTA MEDICA PORTUGUESA, 2017, 30 (06): : 443 - 448
  • [48] Visceral leishmaniasis unresponsive to antimonial drugs: Risk factors and treatment
    Piarroux, R
    Garnier, JM
    Gambarelli, F
    Dumon, H
    Kaplanski, S
    Unal, D
    ARCHIVES DE PEDIATRIE, 1996, 3 (04): : 352 - 356
  • [49] Cytokine expression in the duodenal mucosa of patients with visceral leishmaniasis
    Luz, Kleber Giovanni
    Tuon, Felipe Francisco
    Duarte, Maria Irma Seixas
    Maia, Guilherme Mariz
    Matos, Paulo
    de Oliveira Ramos, Ana Maria
    Nicodemo, Antonio Carlos
    REVISTA DA SOCIEDADE BRASILEIRA DE MEDICINA TROPICAL, 2010, 43 (04) : 393 - 395
  • [50] Energy metabolism as a target for cyclobenzaprine: A drug candidate against Visceral Leishmaniasis
    Lima, Marta Lopes
    Abengozar, Maria A.
    Torres-Santos, Eduardo Caio
    Borborema, Samanta Etel Treiger
    Godzien, Joanna
    Lopez-Gonzalvezd, Angeles
    Barbas, Coral
    Rivas, Luis
    Tempone, Andre Gustavo
    BIOORGANIC CHEMISTRY, 2022, 127
12345